Zhejiang Orient Gene Biotech Co Ltd (688298) - Total Liabilities

Latest as of September 2025: CN¥1.01 Billion CNY ≈ $148.51 Million USD

Based on the latest financial reports, Zhejiang Orient Gene Biotech Co Ltd (688298) has total liabilities worth CN¥1.01 Billion CNY (≈ $148.51 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 688298 asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Zhejiang Orient Gene Biotech Co Ltd - Total Liabilities Trend (2016–2024)

This chart illustrates how Zhejiang Orient Gene Biotech Co Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see 688298 current and non-current assets.

Zhejiang Orient Gene Biotech Co Ltd Competitors by Total Liabilities

The table below lists competitors of Zhejiang Orient Gene Biotech Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Shandong Astro-century Education&Technology Co Ltd SHE:300654	China	CN¥220.96 Million
SECHE ENVIRO.UNSP.ADR 1/5 F:SCB0	Germany	€1.67 Billion
Abacus Group AU:ABG	Australia	AU$1.04 Billion
Yongji Printing Co Ltd SHG:603058	China	CN¥793.86 Million
ZH.JIN.ENV.HLDG DL-00001 F:3UG	Germany	€16.31 Billion
Hailir Pesticides and Chemicals Group Co Ltd SHG:603639	China	CN¥3.42 Billion
Meorient SHE:300795	China	CN¥208.64 Million
Sjóvá-Almennar tryggingar hf IC:SJOVA	Iceland	Ikr52.63 Billion

Liability Composition Analysis (2016–2024)

This chart breaks down Zhejiang Orient Gene Biotech Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Zhejiang Orient Gene Biotech Co Ltd balance sheet independence to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	4.28	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.16	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.14	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Zhejiang Orient Gene Biotech Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Zhejiang Orient Gene Biotech Co Ltd (2016–2024)

The table below shows the annual total liabilities of Zhejiang Orient Gene Biotech Co Ltd from 2016 to 2024.

Year	Total Liabilities	Change
2024-12-31	CN¥1.30 Billion ≈ $190.69 Million	-9.89%
2023-12-31	CN¥1.45 Billion ≈ $211.63 Million	-39.25%
2022-12-31	CN¥2.38 Billion ≈ $348.38 Million	+14.01%
2021-12-31	CN¥2.09 Billion ≈ $305.57 Million	+86.14%
2020-12-31	CN¥1.12 Billion ≈ $164.16 Million	+944.66%
2019-12-31	CN¥107.38 Million ≈ $15.71 Million	-17.15%
2018-12-31	CN¥129.62 Million ≈ $18.97 Million	+6.94%
2017-12-31	CN¥121.20 Million ≈ $17.74 Million	-14.82%
2016-12-31	CN¥142.28 Million ≈ $20.82 Million	--

About Zhejiang Orient Gene Biotech Co Ltd

SHG:688298 China Medical Devices

Market Cap

$527.76 Million

CN¥3.61 Billion CNY

Market Cap Rank

#12076 Global

#3497 in China

Share Price

CN¥17.89

Change (1 day)

-0.72%

52-Week Range

CN¥17.47 - CN¥28.54

All Time High

CN¥221.47